important new report: benefit of TDM1 after herceptin + perjeta raises?

[phil]

I hope they follow the trial results comparing t dm-1 / pert. vs. pert with herc / taxanes further out to track longer term survival outcomes for stage ivs. my sense is that tdm-1 , with it's targeted chemo homing in directly on mutated her2 cells, will outperform whole body , diffused chemos like taxotere , capecitabine , etc.
pert. is a genetic, not a chemo, and has to be paired with chemos to get full effect on refractory metastatic her2 disease.